Research on benefits of CBD Oil

Has Antipsychotic Effects

Research shows that CBD benefits include producing antipsychotic effects. It appears to have a pharmacological profile similar to that of atypical antipsychotic drugs as seen using behavioral and neurochemical techniques in animal studies. Additionally, studies show that CBD prevents human experimental psychosis and is effective in open case reports and clinical trials in patients with schizophrenia, with a remarkable safety profile.

Reduces Anxiety

Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. Cannabidiol has shown to reduce anxiety in patients with social anxiety disorder and researchers suggest that it may also be effective for panic disorder, obsessive compulsive disorder, social anxiety disorder and post-traumatic stress disorder.A 2011 study aimed to compare the effects of a simulation public speaking test on healthy control patients and treatment-native patients with social anxiety disorder. A total of 24 never-treated patients with social anxiety disorder were given either CBD or placebo 1.5 hours before the test. Researchers found that pretreatment with CBD significantly reduced anxiety, cognitive impairment and discomfort in their speech performance, and significantly decreased alertness in anticipation of their speech. The placebo group presented higher anxiety, cognitive impairment and discomfort.

Several scientific reports demonstrate that CBD benefits include possessing antiproliferative, pro-apoptotic effects that inhibit cancer cell migration, adhesion and invasion. A 2006 study published in the Journal of Pharmacology and Experimental Therapeutics found for the first time that CBD potently and selectively inhibited the growth of different breast tumor cell lines and exhibited significantly less potency in non-cancer cells. 

In 2011, researchers added light on the cellular mechanism through which CBD induces cell death in breast cancer cells. They showed that CBD induced a concentration-dependent cell death of both oestrogen receptor-positive and oestrogen receptor-negative breast cancer cells. They also found that the effective concentrations of CBD in tumor cells have little effect on non-tumorigenic, mammary cells. 

CBD behaves as a non-toxic compound and studies show that doses of 700 milligrams per day for 6 weeks did not show any overt toxicity in humans, suggesting that it can be used for prolonged treatment. Not only does the research show that CBD benefits including being effective in fighting breast cancer cells, data also suggests that it can be used to inhibit the invasion of lung and colon cancer, plus it possesses anti-tumor properties in gliomas and has been used to treat leukemia. 

Relieves Nausea

Cannabis has been used for centuries for the suppression of nausea and vomiting. Research has revealed that among more than 80 cannabinoid compounds found in marijuana, both the intoxicant THC and the non-intoxicant CBD helps to get rid of nausea and vomiting in animal studies. A 2012 study published in the British Journal of Pharmacology found that CBD benefits including possessing anti-nausea and antiemetic effects when it was administered to rats. (13) Researchers found that CBD acts in a diphasic manner, meaning that in low doses it suppresses toxin-induced vomiting, but in high doses it increases nausea or has no effect.

May Treat Seizures and Other Neurological Disorders

A 2014 survey conducted by researchers at Stanford University was presented to parents belonging to a Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis to treat their child’s seizures. Nineteen responses met the inclusion criteria for the study: a diagnosis of epilepsy and current use of CBD-enriched cannabis. The average number of anti-epileptic drugs tried before using CBD cannabis was 12. Sixteen (84 percent) of the 19 parents reported a reduction in their child’s seizure frequency while taking CBD cannabis. Of these, two (11 percent) reported complete seizure freedom, eight (42 percent) reported a greater than 80 percent reduction in seizure frequency, and six (32 percent) reported a 25–60 percent seizure reduction. Other beneficial effects included increased alertness, better mood and improved sleep; while side effects included drowsiness and fatigue. 

Later in 2014, researchers reported on preliminary results of a study involving children with treatment-resistant epilepsies in an expanded access “compassionate use program.” Patients received a purified 98 percent oil-based CBD extract called Epidiolex, which is made by GW Pharmaceuticals. After 3 months of treatment, 39 percent of the 23 patients had more than a 50 percent reduction in seizures, with a 32 percent median reduction. These preliminary results support the animal studies and survey reports that CBD may be a promising treatment for treatment-resistant epilepsy and it is generally well-tolerated in doses up to 25 milligrams per kilogram of body weight. 

Lowers Incidence of Diabetes

A 2006 study found that CBD treatment significantly reduced the incidence of diabetes in non-obese diabetic mice from an incidence of 86 percent in non-treated mice to an incidence of 30 percent in CBD-treated mice. CBD benefits also showed a significant reduction of plasma levels of pro-inflammatory cytokines. A histological examination of the pancreatic islets of the CBD-treated mice revealed significantly reduced insulitis. 

In 2013, the American Journal of Medicine published a study that highlighted the impact of marijuana use on glucose, insulin and insulin resistance among U.S. adults. The study included 4,657 adult men and women from the National Health and Nutritional Examination Survey from 2005 to 2010. Of the participants, 579 were current marijuana users and 1,975 were past users. The researchers found that current marijuana use was associated with 16 percent lower fasting insulin levels. They also found significant associations between marijuana use and smaller waist circumferences, a factor connected to the onset of diabetes symptoms. 

Empowering Australians to Conquer Chronic Pain: The Role of Medical Cannabis

In the vast landscape of healthcare, few challenges are as pervasive and debilitating as chronic pain. For countless Australians, the quest for relief from unrelenting discomfort has led to a renewed focus on an unconventional yet promising ally: medical cannabis.

The Unrelenting Burden of Chronic Pain

Chronic pain, often defined as persistent discomfort lasting for months or even years, affects millions of lives across Australia. It not only takes a physical toll but also casts a shadow over one's emotional and mental well-being. Conventional treatments, such as opioids, often come with the baggage of addiction and severe side effects, leaving patients in a difficult and often hopeless situation.

A Natural Solution with Ancient Roots

The use of cannabis for pain management is far from a new concept. Ancient civilizations recognized the plant's potential to alleviate suffering, and modern science is beginning to validate these age-old insights. Cannabis contains a multitude of compounds, the most well-known being cannabidiol (CBD) and tetrahydrocannabinol (THC), both of which play a significant role in its pain-relieving properties.

The Mechanism of Relief: Unlocking the Endocannabinoid System

The human body has its own built-in regulatory system known as the endocannabinoid system (ECS). It consists of receptors, endocannabinoids (naturally occurring compounds within the body), and enzymes that work together to maintain balance or homeostasis. Medical cannabis interacts with the ECS, influencing pain perception, inflammation, and even immune responses.

A Growing Body of Evidence

As Australia continues to navigate the complex terrain of medical cannabis, research is shedding light on its potential role in chronic pain management. Scientific studies and clinical trials have revealed promising results, showing that medical cannabis can effectively reduce pain, improve sleep, and enhance overall quality of life for those grappling with chronic pain conditions.

Charting a New Path to Relief

Our comprehensive guide, "The Role of Medical Cannabis in Treating Chronic Pain in Australia," embarks on a journey of exploration into the transformative potential of medical cannabis. Join us as we navigate the intricate world of cannabis, delve into the latest scientific findings, and share compelling stories of individuals who have found renewed hope and vitality through this natural solution. Together, we embark on a mission to empower Australians to conquer chronic pain and embrace a life with less suffering.

Unlocking the Connection: Medical Cannabis and the Immune System

In the realm of healthcare and scientific research, the intricate dance between medical cannabis and the immune system has emerged as a topic of profound importance and endless fascination. As our understanding of the human body's defence mechanisms deepens, so does our recognition of the potential of cannabis to modulate and influence the immune response.

The Immune System: Guardian of Health

The immune system, a remarkable network of cells, tissues, and organs, stands as our body's stalwart guardian against threats ranging from infections to cancers. Its ability to distinguish friend from foe, launching precise attacks when needed and maintaining a state of equilibrium, is nothing short of awe-inspiring.

Cannabis: An Ancient Healer with Modern Promise

Throughout history, various cultures have turned to cannabis as a remedy for a multitude of ailments. Today, scientific inquiry and medical exploration are unveiling the secrets of this ancient healer. Cannabis contains compounds known as cannabinoids, with cannabidiol (CBD) and tetrahydrocannabinol (THC) at the forefront. These cannabinoids, among others, possess the potential to interact with the immune system in profound ways.

The Endocannabinoid System (ECS): A Bridge of Communication

At the heart of this interaction lies the endocannabinoid system (ECS), a complex web of receptors, endocannabinoids (naturally occurring compounds in our bodies), and enzymes. This system plays a pivotal role in regulating various physiological processes, including immune responses. Medical cannabis, with its ability to mimic our body's own endocannabinoids, can communicate with the ECS, influencing immune activities, inflammation, and even cell apoptosis.

A New Frontier in Healthcare

As the medical community embarks on a journey to understand the intricacies of medical cannabis and the immune system, promising research emerges. Studies have shown that cannabis has the potential to alleviate symptoms of autoimmune disorders, modulate immune responses in cases of chronic inflammation, and enhance the body's ability to combat diseases.

Exploring the Nexus: Medical Cannabis and the Immune System

Our comprehensive guide, Medical Cannabis and the Immune System, invites you to embark on a captivating journey through the intertwining realms of science, medicine, and the natural world. Together, we delve into the fascinating mechanisms that underlie the relationship between medical cannabis and the immune system. Join us in uncovering the latest research, promising treatments, and the potential of this ancient healer to shape the future of healthcare.